Compare HROW & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | WABC |
|---|---|---|
| Founded | 1998 | 1972 |
| Country | United States | United States |
| Employees | 373 | 627 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 1994 |
| Metric | HROW | WABC |
|---|---|---|
| Price | $42.21 | $58.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $69.86 | $54.00 |
| AVG Volume (30 Days) | ★ 752.2K | 142.1K |
| Earning Date | 05-11-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.40 |
| Revenue | N/A | N/A |
| Revenue This Year | $31.62 | N/A |
| Revenue Next Year | $50.77 | N/A |
| P/E Ratio | ★ N/A | $16.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.54 | $44.93 |
| 52 Week High | $54.98 | $59.00 |
| Indicator | HROW | WABC |
|---|---|---|
| Relative Strength Index (RSI) | 71.20 | 67.70 |
| Support Level | $40.61 | $46.43 |
| Resistance Level | $51.01 | N/A |
| Average True Range (ATR) | 2.10 | 1.28 |
| MACD | 1.07 | 0.13 |
| Stochastic Oscillator | 96.39 | 75.96 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.